30/09/2004 Merck pulls Vioxx, its best-selling drug, for safety reasons
2:21
merck minimized the true risks of vioxx
3:07
Merck recalls blockbuster arthritis drug
2:27
Vioxx and FDA Drug Injuries
3:40
Vioxx - Drugs-Inhibitors - WNBC-TV 4 NY - August 27 2007
Rofecoxib is a nonsteroidal anti-inflammatory drug that has now been withdrawn over safety concerns. It was marketed by Merck & Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhea. Rofecoxib was approved by the U.S. Food and Drug Administration in 1999 and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx.